De novo combination therapy in retroviral infection

International Journal of Virology

Volumn 6, Issue 4, 2010, Pages 219-223

  Kadam, N M ^a   Chaudhari, H S ^a   Parikh, J K ^a   Modi, V S ^a   Kokil, S U ^b   Balaramnavar, V M ^c  

^a SSR College of Pharmacy   (India)

^b Department of Pharmaceutical Analysis   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Combination therapy; Natural products; Nucleosidase RT inhibitor; Retroviral infection

Indexed keywords

ACICLOVIR; AMANTADINE; CALANOLIDE A; CALANOLIDE B; CASTANOSPERMINE; GLYCYCOUMARIN; HERBACEOUS AGENT; HYPERICIN; KAURENE DERIVATIVE; LYCOPYRANOCOUMARIN; MICHELLAMINE A; MICHELLAMINE B; MICHELLAMINE C; PENTACYCLICTRITERPINE; PODOPHYLLOTOXIN LIGNAN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SALASPERMIC ACID; SAPONIN; STAVUDINE; TETRAGALLOYLQUINIC ACID; TRACHELOGENIN; TRIPTERIFORDIN; UNCLASSIFIED DRUG; XYPODOPHYLLOTOXIN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CASTANOSPERMUM; COMBINATION CHEMOTHERAPY; DRUG POTENCY; DRUG POTENTIATION; ENZYME INHIBITION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; IPOMOEA; NONHUMAN; PERIPHERAL NEUROPATHY; RETROVIRUS INFECTION; TRIPTERYGIUM; VIRUS INHIBITION;

EID: 78449259946     PISSN: 18164900     EISSN: None     Source Type: Journal    
DOI: 10.3923/ijv.2010.219.223     Document Type: Article

References (10)

1. Hammer, S.M., D.A. Katzenstein, M.D. Hughes, H. Gundacker and R.T. Schooley et al., 1996. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N. Eng. J. Med., 335: 1081-1090.
2. Hilts, A.E. and D.N. Fish, 1998. Dosage adjustment of antiretroviral agents in patients with organ dysfunction. Am. J. Health Syst. Pharm., 55: 2528-2533.
3. Matthee, G., A.D. Wright and G.M. Koenig, 1999. HIV reverse transcriptase inhibitors of natural origin. Planta. Med., 65: 493-506.
4. Meruelo, D., D. Lavie and G. Lavie, 1988. Therapeutic agents with dramatic retroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudohypericin. Proc. Nat. Acad. Sci. USA., 85: 5230-5234.
5. Pawar, V.S., D.K. Lokwani, S. V. Bhandari, K.G. Bothara and T.S. Chitre et al., 2010. Design, docking study and ADME prediction of Isatin derivatives as anti-HIV agents. Med. Chem. Res., 10.1007/s00044-010-9329-y.
6. Sharma, P.C., O.P. Sharma, N. Vasudeva, D.N. Mishra and S.K. Singh, 2006. Anti-HIV substances of natural origin-An updated account. J. Nat. Prod. Rad., 5: 70-78.
7. Taylor, D.L., R. Nash, L.E. Fellows, M.S. Kang and A.S. Tyms, 1992. Naturally occurring pyrrolizidines: Inhibition of a-glucosidase 1 and anti-HIV activity of one stereoisomer. Antivir. Chem. Chemother., 3: 273-277.
8. Vlietinck, A.J., T. De Bruyne, S. Apers and L.A. Pieters, 1998. Plant-derived leading compounds for chemotherapy of Human Immunodeficiency Virus (HIV). Planta Med., 64: 97-109.
9. Volberding, P.A.L., S.W. Grimes, J.M. Stein, D.S. Rooney and J. Meng et al, 1995. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. N. Eng. J. Med., 333: 401-407.
10. Walker, B.D., M. Kowalski, W.C. Goh, K. Kozarsky and M. Krieger, 1987. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc. Nat. Acad. Sci. USA., 84: 8120-8124.